title: Favorable course of pericardial angiosarcoma under paclitaxel followed by pazopanib treatment documented by cardiovascular magnetic resonance imaging.
authors.affiliation: Robert Bosch Medical Centre, Auerbachstr 110, 70376 Stuttgart, Germany. Peter.Ong@rbk.de
authors.forename: Peter
authors.initials: P
authors.lastname: Ong
authors.forename: Simon
authors.initials: S
authors.lastname: Greulich
authors.forename: Julia
authors.initials: J
authors.lastname: Schumm
authors.forename: Maik
authors.initials: M
authors.lastname: Backes
authors.forename: Martin
authors.initials: M
authors.lastname: Kaufmann
authors.forename: Sabine
authors.initials: S
authors.lastname: Bode-Erdmann
authors.forename: German
authors.initials: G
authors.lastname: Ott
authors.forename: Holger
authors.initials: H
authors.lastname: Hebart
authors.forename: Heiko
authors.initials: H
authors.lastname: Mahrholdt
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D057210:Delayed Diagnosis; D003951:Diagnostic Errors; D004317:Doxorubicin / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm; D005047:Etoposide / Q000008:administration & dosage; D006338:Heart Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006394:Hemangiosarcoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007191:Indazoles; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D008297:Male; D009206:Myocardium / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage; D010490:Pericardial Effusion / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D020519:Pericardiocentesis; D010493:Pericarditis / Q000175:diagnosis; D010496:Pericardium / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage; D011655:Pulmonary Embolism / Q000209:etiology; D011743:Pyrimidines / Q000008:administration & dosage*; D012074:Remission Induction; D013449:Sulfonamides / Q000008:administration & dosage*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000305:Adrenal Cortex Hormones; D020533:Angiogenesis Inhibitors; D007191:Indazoles; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D014750:Vincristine; D005047:Etoposide; C516667:pazopanib; D004317:Doxorubicin; D017239:Paclitaxel; D007069:Ifosfamide